Loss of the B-lineage-specific Gene Expression Program in Hodgkin and Reed-Sternberg Cells of Hodgkin Lymphoma
Overview
Authors
Affiliations
Hodgkin and Reed-Sternberg (HRS) cells represent the malignant cells in classical Hodgkin lymphoma (HL). Because their immunophenotype cannot be attributed to any normal cell of the hematopoietic lineage, the origin of HRS cells has been controversially discussed, but molecular studies established their derivation from germinal center B cells. In this study, gene expression profiles generated by serial analysis of gene expression (SAGE) and DNA chip microarrays from HL cell lines were compared with those of normal B-cell subsets, focusing here on the expression of B-lineage markers. This analysis revealed decreased mRNA levels for nearly all established B-lineage-specific genes. For 9 of these genes, lack of protein expression was histochemically confirmed. Down-regulation of genes affected multiple components of signaling pathways active in B cells, including B-cell receptor (BCR) signaling. Because several genes down-regulated in HRS cells are positively regulated by the transcriptional activator Pax-5, which is expressed in most HRS cells, we studied HL cell lines for mutations in the Pax-5 gene. However, no mutations were found. We propose that the lost B-lineage identity in HRS cells may explain their survival without BCR expression and reflect a fundamental defect in maintaining the B-cell differentiation state in HRS cells, which is likely caused by a novel, yet unknown, pathogenic mechanism.
Chemotherapy's effects on autophagy in the treatment of Hodgkin's lymphoma: a scoping review.
Wahyudianingsih R, Sanjaya A, Jonathan T, Pranggono E, Achmad D, Hernowo B Discov Oncol. 2024; 15(1):269.
PMID: 38976168 PMC: 11231119. DOI: 10.1007/s12672-024-01142-6.
Parkhi M, Premkumar M, Bal A, Das A, Jain S, Mitra S Autops Case Rep. 2024; 14:e2024490.
PMID: 38803484 PMC: 11129859. DOI: 10.4322/acr.2024.490.
Clonal composition and differentiation stage of human CD30 B cells in reactive lymph nodes.
Kuppers R, Budeus B, Hartmann S, Hansmann M Front Immunol. 2023; 14:1208610.
PMID: 37559724 PMC: 10407394. DOI: 10.3389/fimmu.2023.1208610.
Chan D, Klein K, Riera-Escamilla A, Krausz C, OFlaherty C, Chan P Clin Epigenetics. 2023; 15(1):5.
PMID: 36611168 PMC: 9826600. DOI: 10.1186/s13148-022-01417-1.
Hodgkin Lymphoma: Biology and Differential Diagnostic Problem.
Takahara T, Satou A, Tsuzuki T, Nakamura S Diagnostics (Basel). 2022; 12(6).
PMID: 35741318 PMC: 9221773. DOI: 10.3390/diagnostics12061507.